Marvin H. Berman

Marvin H. Berman, PhD, CBT, BCN, is a co-founder of Neuronic and directs the clinical consultation and R&D programs for optimizing the effective delivery of its Neuradiant 1070 technology.

He earned his Master’s Degree and PhD Degree in Psychoeducational Processes from Temple University, where he studied group dynamics, training and organizational behavior. He obtained his certification as a Bioenergetic Analyst at the Philadelphia Institute for Bioenergetic Analysis in 1983 and maintained a private practice as a psychotherapist until 2010, when he focused more on applied clinical neuroscience research and consultation on the integration of transcranial photobiomodulation (tPBM) and neuromodulation in treating neuropsychiatric, neurodegenerative and neurodevelopmental disorders. 


Marvin H. Berman's Research on tPBM and Neuroscience

Marvin H. Berman’s group at Quietmind Foundation published the first human clinical studies of 1070nm tPBM on the cognitive and behavioral symptoms associated with early to mid-stage dementia.

He collaborates with Baylor Research Institute and Baylor Scott & White’s Dept of Neurosurgery on trials of self-administered 1070nm pulsed tPBM on cognitive and behavioral symptoms of Alzheimer's Disease and Parkinson’s Disease and integrating tPBM and qEEG at Santa Clara University’s Brain & Memory Care Lab.  

Marvin Berman is currently unavailable for new clients. However, he will consider accepting new clients during the fall as his schedule allows.